Renaissance Technologies’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,800
Closed -$229K 3896
2024
Q3
$229K Sell
15,800
-108,300
-87% -$1.29M ﹤0.01% 3078
2024
Q2
$1.06M Buy
124,100
+111,500
+885% +$989K ﹤0.01% 2291
2024
Q1
$129K Sell
12,600
-39,400
-76% -$294K ﹤0.01% 3323
2023
Q4
$285K Sell
52,000
-85,700
-62% -$375K ﹤0.01% 3011
2023
Q3
$521K Sell
137,700
-166,600
-55% -$1.09M ﹤0.01% 2693
2023
Q2
$2.04M Sell
304,300
-26,300
-8% -$176K ﹤0.01% 1987
2023
Q1
$2.15M Buy
330,600
+19,600
+6% +$151K ﹤0.01% 1986
2022
Q4
$2.65M Sell
311,000
-3,400
-1% -$22.1K ﹤0.01% 1908
2022
Q3
$1.66M Sell
314,400
-234,899
-43% -$1.16M ﹤0.01% 2144
2022
Q2
$2.33M Sell
549,299
-121,243
-18% -$423K ﹤0.01% 2079
2022
Q1
$2.35M Buy
670,542
+302,542
+82% +$1.32M ﹤0.01% 2120
2021
Q4
$2.45M Buy
368,000
+251,400
+216% +$2.04M ﹤0.01% 1982
2021
Q3
$1.16M Buy
+116,600
New +$2.88M ﹤0.01% 2466

Other funds holding SPRY